Researchers and clinicians face ethical and policy-based challenges in disclosing, preventing and treating psychosis. Which diagnostic labels should be considered to motivate more effective public and professional dialogue about psychosis risk?

Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients.

Although the stigma of the psychosis risk label can cause harm, the label can also confer benefit and provides an explanatory framework for symptoms.

Physicians with a mental illness can have good, empathic relationships with their patients, even if patients know of their condition.

CHWs’ work underscores need for clinicians and organizations to respond to deeply entrenched, long-standing patterns of oppression in ways that draw upon lived experience.

On this episode of Ethics Talk, Zahra H. Khan, Yoshiko Iwai, and Dr Sayantani DasGupta outline how “abolition medicine” can motivate critical responses to medicine’s expressions of hyper-punitive, deeply racialized exercises of state authority.

Aminta Kouyate joins Ethics Talk to discuss her article, coauthored with Drs Nhi Tran and Monica U. Hahn: “Why Professionalism Demands Abolition of Carceral Approaches to Patients’ Nonadherence Behaviors.”

Dr Crystal M. Hayes joins Ethics Talk to discuss her article, coauthored with Dr Anu Manchikanti Gomez: “Alignment of Abolition Medicine With Reproductive Justice.”

Russyan Mark Mabeza joins Ethics Talk to discuss his article, coauthored with Betial Asmerom, Dr Rupinder Legha, and Vanessa Nuñez: “An Abolitionist Approach to Antiracist Medical Education.”

Dr Carmen Black joins Ethics Talk to discuss her article, coauthored with Drs Emma Lo and Keith Gallagher: “Community Mental Health Centers’ Roles in Depolicing Medicine.”